DJIA 17,356.87 288.00 1.69%
NASDAQ 4,644.31 96.48 2.12%
S&P 500 2,012.89 40.15 2.04%
market minute promo

303.38 9.71 (3.31%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IBB $303.38 3.31%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $294.74
Previous Close $293.67
Daily Range $293.48 - $303.89
52-Week Range $207.48 - $316.80
Market Cap $6.7B
P/E Ratio -1,276.83
Dividend (Yield) $0.22 (0.2%)
Ex-Dividend Date
Dividend Pay Date
09/24/14
09/30/14
Volume 1,934,207
Average Daily Volume 1,264,894
Current FY EPS $0.00

Sector

Financials

Industry

Financial Services

iShares NASDAQ Biotechnology Index (ETF) (IBB) Description

The investment seeks investment results that correspond generally to the price and yield performance before fees and expenses of the NASDAQ Biotechnology Index (the underlying index). Website: http://www.ishares.com/

News & Commentary Rss Feed

Does George Soros Think Biotech's Bull Run Is Finally Coming to an End?

The Soros Fund Managment sold off a number of biotechs in the third quarter. Do the actions of this closely watched fund signal that the industry's bull run is finally winding down?

Karyopharm Announces Addition to the NASDAQ Biotechnology Index

3 Ways to Be a Smarter Biotech Investor

Three Motley Fools share their thoughts on how to make the best biotech investments.

Biotech ETFs in Focus on Cubist Takeover Deal - ETF News And Commentary

George Soros Is Dumping These 3 Dividend Stocks: Should You?

Billionaire and hedge fund guru George Soros sold Eli Lilly, Johnson & Johnson, and Teva Pharmaceutical in the third-quarter. Should average investors do the same?

Did You Miss This Year's Biggest Investment Themes? Here's Four

A Look At 3 Overbought ETFs

Energy Stocks Lead Market Up Despite Crude Oil Decline

Today's financial recap and tomorrow's financial outlook.

Biotech Weekly: Biotech From The Charts And What I'm Watching Into Year End

3 Biotech Stocks With Jaw-Dropping Growth Potential in 2015

Biotech stocks have been crushing the broader markets in recent years. Here are three biotech companies poised to continue this trend in 2015.

See More IBB News...

IBB's Top Competitors

IBB $303.38 (3.31%)
Current stock: IBB
VTA $11.48 (1.32%)
Current stock: VTA
NCV $8.92 (1.71%)
Current stock: NCV
ZTR $13.56 (-0.51%)
Current stock: ZTR